Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 13,465-13,476 of 23,847
Device study icon
CompletedNCT03653858

Efficacy Study of Deep Brain Stimulation in people with Treatment Resistant Major Depression

This study exists to compare options and see whether the medication Deep offers something meaningfully different. Researchers are trying to understand what the medication Deep can reveal about signals in the brain or body that may guide care later on.

Multiple locations, including Grenoble
DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 20 Years to 75 Years
Countries
France, Germany
Sponsor
University Hospital Freiburg
Condition
Depression
Drug study icon
TerminatedNCT01093963

Efficacy Study of Lisdexamfetamine to Treat Depression in bipolarity

This study exists to understand whether the medication Lisdexamfetamine is both safe enough and useful enough to take further. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

In Mason
Bipolarity, DepressionDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Lindner Center of HOPE
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01393613

Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Colombia, Croatia, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00401089

Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Kingston
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Canada, United Kingdom
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.